Antibiotic and Cytotoxic Activity of Brominated Compounds from the Marine Sponge Verongia aerophoba

  title={Antibiotic and Cytotoxic Activity of Brominated Compounds from the Marine Sponge Verongia aerophoba},
  author={R. Teeyapant and Herman J. Woerdenbag and Peter Kreis and J K Hacker and Victor Wray and Ludger Witte and Peter Proksch},
  journal={Zeitschrift f{\"u}r Naturforschung C},
  pages={939 - 945}
Abstract Analysis of the marine sponge Verongia aerophoba from the Canary Islands afforded eight brominated secondary metabolites including the small molecular weight compounds aeroplysinin-1 (5) and the dienone (7) which were previously shown to arise by enzymatically catalyzed degradation of aerophobin-2 (4) and isofistularin-3 (1) following breakdown of the cellular compartmentation of the sponge. All compounds were identified from their NMR and mass spectra. Aeroplysinin-1 as well as… 

Tables from this paper

Marine biomaterials: Biomimetic and pharmacological potential of cultivated Aplysina aerophoba marine demosponge.

Bioactive natural products from marine sponges and fungal endophytes

The activated chemical defence of the Mediterranean sponge Aplysina aerophoba is introduced as an example of a dynamic response of marine sponges to wounding and a preliminary characterization of the membrane bound enzyme(s) involved in the cleavage reaction is presented.

An Aeroplysinin-1 Specific Nitrile Hydratase Isolated from the Marine Sponge Aplysina cavernicola

The enzymes were shown to be manganese dependent, although cobalt and nickel ions were also able to recover the activity of the nitrile hydratases, and showed high substrate specificity towards the physiological substrate aeroplysinin-1.

Targeted Isolation of Antibiotic Brominated Alkaloids from the Marine Sponge Pseudoceratina durissima Using Virtual Screening and Molecular Networking

A unique method of targeted isolation using structure-based virtual screening to identify potential antibacterial compounds active against MRSA within the marine sponge order Verongiida is used to provide a novel drug discovery procedure.

Expression of secondary metabolites by the Mediterranean sponges Aplysina aerophoba and Aplysina cavernicola

  • N. Majdi
  • Environmental Science, Biology
  • 2008
The methodology to quantify the major secondary metabolites produced by the two Mediterranean Aplysina species is finalized, chemotaxonomic markers are identified in order to clearly discriminate the two sibling species, and the role of microbial symbionts in bromotyrosine alkaloids biosynthesis is investigated.

Temporal Trends in the Secondary Metabolite Production of the Sponge Aplysina aerophoba

The present study is one of the first to document quantitative seasonal variations in individual compounds over multiple years, and the role of environmental, biological, and physiological factors in determining the seasonal patterns in the concentration of brominated alkaloids is clarified.

Activated Chemical Defense in Aplysina Sponges Revisited

It is concluded that tissue damage induces a bioconversion of isoxazoline alkaloids into aeroplysinin-1 and dienone in Aplysina sponges, and this reaction is likely catalyzed by enzymes, and it may be ecologically relevant as theBioconversion products possibly protect the wounded sponge tissue from invasion of bacterial pathogens.

Natural Products from Sponges

Development of recombinant microorganisms engineered for efficient production of sponge-derived products is a promising strategy that deserves further attention in future investigations in order to address the limitations regarding sustainable supply of marine drugs.



Sec­ ondary Metabolites from Marine Sponges

  • Ullstein Mosby, Berlin
  • 1993

The Search for Antiviral and Anticancer Compounds from Marine Organisms

A survey is presented of the occurence of compounds from marine source, other than microorganisms, which have been reported to have antiviral, antitumor or cytotoxic properties. The biological data


  • S. Austad
  • Environmental Science
    Experimental Gerontology
  • 1991


  • Apoth. Ztg. 132, 673
  • 1992